Coronavirus latest update: Maharashtra count increases to 2,334 with 352 new cases; death toll 160
NEW DELHI: Delhi and Maharashtra witnessed a large increase in Covid-19 cases on Monday with the capital registering 356 new cases and the western state 352, their highest single-day records. India's Covid-19 count has now crossed the 10,000 mark. The overall count includes 1,211 new cases on Monday, the highest so far by a large margin and a sharp 67% rise from the number reported on Sunday (763). 31 deaths were also reported in the past 24 hours.
Here's a look at the latest updates on the coronavirus outbreak in India and around the world:
The Maharashtra Covid-19 count rises to 2,334 with 352 new cases; death toll 160
The number of Covid-19 cases in Maharashtra on Monday crossed the 2000 mark, with 352 more people, including 242 from Mumbai, who tested positive for the coronavirus. While the total number of cases increased to 2,334, the number of deaths increased to 160, and 11 more people succumbed to the infection on Monday.
Virus cases around 2 million worldwide
The number of New York coronavirus deaths exceeded 10,000 and the global number of confirmed cases was around 2 million on Monday. The worst part of the disease has been felt most intensely in New York, Italy, France, Spain and the United Kingdom.
An online panel tracking the global number of confirmed coronavirus cases, maintained by Johns Hopkins University, on Monday night showed that the number of cases in the US USA It approaches 683,000, with more than 2 million worldwide. Subsequently, the site was adjusted to reflect nearly 582,000 cases in the United States. USA And 1.9 million cases worldwide. It was not immediately clear why the numbers changed.
China approves two experimental coronavirus vaccines to participate in clinical trials
China approved early-stage human testing for two experimental vaccines to fight the new coronavirus that killed more than 100,000 people worldwide, the state-run Xinhua news outlet said on Tuesday.
The vaccines are being developed by a Beijing-based unit of Sinovac Biotech listed on Nasdaq, and by the Wuhan Biological Products Institute, a subsidiary of China's state-owned national pharmaceutical group.
Encouraging results for drugs, India joins trials
India is part of the WHO 'solidarity trials' for the drug Remdesivir, which has shown encouraging results in critically ill Covid-19 patients who need increased oxygen and ventilator support, and will be able to access any benefit from once antiviral medication is established for clinical use. The tests showed significant benefits for two thirds of patients with severe symptoms in 4 countries.
How Kerala managed to flatten the Covid chart
As early as January 18, the state health department issued a Covid-19 alert and began examining passengers arriving from abroad, initially from China. International arrivals were issued a health card listing their travel details and health status. During the following week, he established district control rooms, began acquiring masks, gloves, other PPE, and medications.
Free tests in private laboratories only for the poor: Supreme Court
In a clarification expected to increase testing for Covid-19 by private laboratories, the Supreme Court has said that its direction to provide free testing at non-governmental facilities will apply to economically weaker sectors of society and to people who they can afford it. You will have to pay the cost of Rs 4,500 as set by the Center. Testing in government hospitals is now free for everyone.